These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22199302)

  • 1. Estrogen pathway polymorphisms and mammographic density.
    Dumas I; Diorio C
    Anticancer Res; 2011 Dec; 31(12):4369-86. PubMed ID: 22199302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in genes involved in the estrogen pathway and mammographic density.
    Dumas I; Diorio C
    BMC Cancer; 2010 Nov; 10():636. PubMed ID: 21092186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.
    Ferlin A; Ganz F; Pengo M; Selice R; Frigo AC; Foresta C
    Endocr Relat Cancer; 2010 Mar; 17(1):17-25. PubMed ID: 19776291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
    Long JR; Cai Q; Shu XO; Cai H; Gao YT; Zheng W
    Pharmacogenet Genomics; 2007 May; 17(5):331-8. PubMed ID: 17429315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.
    Rebbeck TR; Troxel AB; Wang Y; Walker AH; Panossian S; Gallagher S; Shatalova EG; Blanchard R; Bunin G; DeMichele A; Rubin SC; Baumgarten M; Berlin M; Schinnar R; Berlin JA; Strom BL
    J Natl Cancer Inst; 2006 Sep; 98(18):1311-20. PubMed ID: 16985250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study.
    Lord SJ; Mack WJ; Van Den Berg D; Pike MC; Ingles SA; Haiman CA; Wang W; Parisky YR; Hodis HN; Ursin G
    Breast Cancer Res; 2005; 7(3):R336-44. PubMed ID: 15987428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women.
    Sangrajrang S; Sato Y; Sakamoto H; Ohnami S; Laird NM; Khuhaprema T; Brennan P; Boffetta P; Yoshida T
    Int J Cancer; 2009 Aug; 125(4):837-43. PubMed ID: 19415745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms.
    Delort L; Satih S; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
    Nutr Cancer; 2010; 62(2):243-51. PubMed ID: 20099199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.
    Sainz J; Rudolph A; Hein R; Hoffmeister M; Buch S; von Schönfels W; Hampe J; Schafmayer C; Völzke H; Frank B; Brenner H; Försti A; Hemminki K; Chang-Claude J
    Endocr Relat Cancer; 2011 Apr; 18(2):265-76. PubMed ID: 21317201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
    Saintot M; Malaveille C; Hautefeuille A; Gerber M
    Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer.
    Udler MS; Azzato EM; Healey CS; Ahmed S; Pooley KA; Greenberg D; Shah M; Teschendorff AE; Caldas C; Dunning AM; Ostrander EA; Caporaso NE; Easton D; Pharoah PD
    Int J Cancer; 2009 Dec; 125(11):2687-96. PubMed ID: 19551860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.
    Hevir-Kene N; Rižner TL
    Chem Biol Interact; 2015 Jun; 234():309-19. PubMed ID: 25437045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in steroid hormone pathway genes and mammographic density.
    Haiman CA; Hankinson SE; De Vivo I; Guillemette C; Ishibe N; Hunter DJ; Byrne C
    Breast Cancer Res Treat; 2003 Jan; 77(1):27-36. PubMed ID: 12602902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density.
    Haakensen VD; Biong M; Lingjærde OC; Holmen MM; Frantzen JO; Chen Y; Navjord D; Romundstad L; Lüders T; Bukholm IK; Solvang HK; Kristensen VN; Ursin G; Børresen-Dale AL; Helland A
    Breast Cancer Res; 2010; 12(4):R65. PubMed ID: 20799965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women.
    Crandall CJ; Sehl ME; Crawford SL; Gold EB; Habel LA; Butler LM; Sowers MR; Greendale GA; Sinsheimer JS
    Breast Cancer Res; 2009; 11(4):R51. PubMed ID: 19630952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast density and polymorphisms in genes coding for CYP1A2 and COMT: the Multiethnic Cohort.
    Takata Y; Maskarinec G; Le Marchand L
    BMC Cancer; 2007 Feb; 7():30. PubMed ID: 17295924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women.
    Ghisari M; Eiberg H; Long M; Bonefeld-Jørgensen EC
    Environ Health; 2014 Mar; 13(1):19. PubMed ID: 24629213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.
    Cheng TC; Chen ST; Huang CS; Fu YP; Yu JC; Cheng CW; Wu PE; Shen CY
    Int J Cancer; 2005 Jan; 113(3):345-53. PubMed ID: 15455371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of mammographic density and gene variants in healthy women.
    Maskarinec G; Lurie G; Williams AE; Le Marchand L
    Int J Cancer; 2004 Nov; 112(4):683-8. PubMed ID: 15382051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
    Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
    Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.